๐ŸŽ—๏ธ OncologyInjection (SC)

    Elrexfio

    Elranatamab

    BCMA-directed bispecific T-cell engager for relapsed/refractory multiple myeloma.

    Form

    Injection (SC)

    Uses

    1

    Side effects

    5

    Category

    Oncology

    01

    What is Elrexfio used for?

    • Relapsed/refractory multiple myeloma
    02

    Elranatamab side effects

    The following side effects have been reported for Elranatamab. Their order does not indicate how often an effect occurs.

    Cytokine release syndrome
    Infections
    ICANS (neurotoxicity)
    Neutropenia
    Anemia
    03

    Elranatamab warnings & precautions

    • Black box: CRS and neurologic toxicity
    • REMS required. Step-up dosing
    • Serious infections

    Loading FDA dataโ€ฆ

    04

    Frequently asked questions

    05

    Related medications

    Share

    Share this drug info.

    Help friends and family understand Elrexfio in plain language.

    Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.